0 633

Cited 3 times in

Effect-site concentration of remifentanil for attenuating QTc interval prolongation following intubation in hypertensive female patients

Authors
 E. J. Kim  ;  D. W. Han  ;  M. K. Song  ;  S. Y. Choi  ;  S. Y. Kim 
Citation
 ACTA ANAESTHESIOLOGICA SCANDINAVICA, Vol.59(10) : 1269-1277, 2015 
Journal Title
ACTA ANAESTHESIOLOGICA SCANDINAVICA
ISSN
 0001-5172 
Issue Date
2015
MeSH
Adult ; Aged ; Electrocardiography/drug effects* ; Female ; Heart Rate ; Humans ; Hypertension/physiopathology* ; Intubation, Intratracheal* ; Middle Aged ; Piperidines/administration & dosage ; Piperidines/pharmacokinetics ; Piperidines/pharmacology*
Abstract
BACKGROUND: Haemodynamic changes after sympathetic stimuli like tracheal intubation are more pronounced in hypertensive patients than in normotensive patients. Heart rate (HR)-corrected QT (QTc) interval changes related to intubation may also be more prominent in hypertensive patients. We hypothesised that there would be a difference in the effect-site concentration (Ce) of remifentanil to attenuate QTc interval prolongation in normotensive and hypertensive patients following intubation.

METHODS: Twenty-two normotensive and 22 hypertensive female patients (≥ 50 year) were enrolled and anaesthesised with remifentanil and propofol using a target-controlled infusion. All hypertensive patients received oral antihypertensive medications for > 6 months and took the medications in the morning of the surgery. The effective concentration of remifentanil Ce in 50% (EC50 ) and 95% of the population (EC95 ) required to maintain QTc interval prolongation < 15 ms following intubation was calculated using the isotonic regression and a bootstrapping approach following the Dixon's up-and-down method.

RESULTS: Median duration of hypertension was 6 years. Isotonic regression revealed that the EC50 (83% confidence interval) of remifentanil Ce for reducing QTc interval prolongation following intubation was 3.8 (3.5-4.1) ng/ml in normotensive and 6.1 (5.8-6.2) ng/ml in hypertensive female patients. The EC95 (95% confidence interval) of remifentanil Ce was 4.4 (4.3-4.5) ng/ml in normotensive and 6.5 (6.4-6.5) ng/ml in hypertensive female patients.

CONCLUSION: The Ce of remifentanil required to attenuate QTc interval prolongation following intubation was significantly higher in hypertensive patients than it was in normotensive patients. Thus, more caution should be taken related to QTc interval prolongation when intubating hypertensive patients.
Full Text
http://onlinelibrary.wiley.com/doi/10.1111/aas.12578/abstract
DOI
10.1111/aas.12578
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Anesthesiology and Pain Medicine (마취통증의학교실) > 1. Journal Papers
1. College of Medicine (의과대학) > Yonsei Biomedical Research Center (연세의생명연구원) > 1. Journal Papers
Yonsei Authors
Kim, So Yeon(김소연) ORCID logo https://orcid.org/0000-0001-5352-157X
Kim, Eun Jung(김은정) ORCID logo https://orcid.org/0000-0002-5693-1336
Song, Mi Kyung(송미경)
Han, Dong Woo(한동우) ORCID logo https://orcid.org/0000-0002-8757-663X
URI
https://ir.ymlib.yonsei.ac.kr/handle/22282913/141446
사서에게 알리기
  feedback

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse

Links